- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Dasatinib – July 2014
Dasatinib, tablets, 20 mg, 50 mg, 70 mg and 100 mg, Sprycel®, Bristol Myers Squibb Australia Pty Ltd
Last updated
8 November 2023